Tessera Therapeutics
Kyle McLaughlin is a seasoned research professional with extensive experience in the biotechnology field. Currently serving as a Senior Research Associate at Tessera Therapeutics since November 2021, Kyle previously held similar positions at PlateletBio and gained foundational research experience at the University of Vermont. Kyle earned a Bachelor of Science degree in Biology from the University of Vermont, complementing academic achievements with practical experience as a Research Associate and Undergraduate Research Assistant. Kyle also possesses previous experience in leadership and teamwork, having worked as an Intramural Sports Supervisor and a Summer Camp Counselor at Winona Camps.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.